Zhongchao Inc - Class A risk profile
47 Elevated one input has moved against it
Measured 21 October 2026 from ZCMD's filed statements. Recomputed nightly.
47 (Elevated), driven by Operating pressure at 81, over 4 weighted categories on the SOFTWARE profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | Reads pct_below_52w_high, volatility_1y_pct and avg_turnover_90d_usd. No reading is stored for this company. | |||
| Operating pressure | 81 | Acute | Stable | Costs outgrowing revenue — +36.7 percentage points |
| Cash conversion | 33 | Normal | Easing | Capital spending against operating cash — 0.18x |
| Leverage and coverage | 0 | Contained | Stable | Net debt to EBITDA |
| Competitive position | 47 | Elevated | Stable | Revenue-growth gap against peers — -25.2 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Healthcare companies with a risk reading
Lilly(Eli) & Company 33Johnson & Johnson 39Abbvie Inc 57Unitedhealth Group Inc 43Roche Holding AG 35Merck & Co Inc 35Novartis AG 29Novartis AG 31Astrazeneca plc 33Thermo Fisher Scientific Inc 44AMGEN Inc 47Gilead Sciences Inc 51
Financials, valuation and price history for Zhongchao Inc - Class A